Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Fluxion Biosciences

384 Oyster Point Blvd. #6
San Francisco, CA 94080
(650) 241-4777
Website Company Summary Management Team

CEO: Jeff Jensen (11/30/2006)
General Management: Steve Kushman

Outside board: (May no longer be on the board) Kenneth Kelley (Ardea Biosciences) John Steuart (Claremont Creek Ventures Managing Director) Elaine Heron (Labcyte CEO) Andrey J Zarur (Kodiak Venture Partners)

Business description: Fluxion Biosciences has developed the revolutionary CellFlux microfluidics technology for conducting critical research and drug discovery at the cellular level. The CellFlux platform delivers a robust, high-performance, economical solution for single-cell analysis. Fluxion develops and markets scientific instruments, software, and consumables which serve the life science research and biopharmaceutical sectors, targeting applications such as cystic fibrosis and leukemia research, antibiotics development, and drug toxicity screening.

Rounds: 4
Recent Fundings: Oct 2012   Oct 2007
Capital raised: 9.0M
Last Round: 2.0M
Ownership: Private  

Last Tweets


Last Mentions

Record updated: Feb 2017
Sector: Biotech
Year Founded: 2005
Rounds: 4
Recent Fundings: Oct 2012   Oct 2007
Capital Raised: 9.0M
Last Round: 2.0M
Ownership: Private